Subscribe to the MEDICI Inner Circle Membership and gain access to an exclusive WhatsApp community where you can engage in discussions with global industry experts!
DataRobot provides a machine learning-based platform for predictive analysis that helps data scientists gain insights for various industries like insurance companies, banks, healthcare, FinTech, and other businesses.The platform can be used to build and deploy highly accurate machine learning models across business functions.DataRobot builds, tests and refines hundreds of models to help data scientists find the ones best suited for their data. The investigation is transparent, allowing users to trace and verify the validity of its results. Users can also code, train, test and compare their own models on the platform. DataRobot also finds key drivers in business metrics, identifies key words and phrases within unstructured text, and showcases the findings.through basic visualisation.
PRODUCTS & SERVICES
The platform helps data scientists to accelerate their predictive model selection and deployment. It evaluates hundreds of machine learning algorithms in order to discover, deploy, and customize the best suited predictive models for every situation. The platform can be used by data science apprentices, business analysts, data scientists, executives, software engineers and IT professionals.
The company follows subscription pricing model.
Global System Integrators
VALUATION / MARKET CAP:
$1 B in 2019
In the latest funding, the company's valuation is more than $1 Bn. (July 2019)
$10M+ in 2016
The company had revenue of $20 million in 2016
In 2017 DataRobot bought Nutonian. In 2018, it acquired Nexosis, and in 2019 it has purchased two startups, Cursor and ParallelM.
BOARD MEMBERS AND ADVISORS
NUMBER OF EMPLOYEES
Jeremy Achin (CEO); Thomas DeGodoy (CTO); Matthew Cain (CFO); Chris Devaney (COO)
DATE OF LAST FUNDING
TOTAL FUNDING COMMENT
The company will use funds to develop its artificial intelligence software and automated machine learning. (July 19)
SEED & PRIOR FUNDING
SEED CLOSED ON
SERIES A · $21 M · Aug 2014
SERIES B · $33 M · Feb 2016
SERIES C · $67.18 M · Mar 2018
SERIES D · $100 M · Oct 2018
SERIES E · $200 M · Jul 2019
Sign up for 7 days free trial with MEDICI Inner Circle to follow and track profiles you care about.